Helix Acquisition Corp. III completed an upsized initial public offering in January 2026, raising $172.5 million including the full exercise of the underwriter's option. The company placed the proceeds in a trust account to be used for a future business combination.

• Helix Acquisition Corp. III announced the closing of its $172.5 million initial public offering, including the full exercise of the underwriter's option to purchase additional shares, on January 27, 2026 [N1].
• The company priced an upsized $150 million IPO on January 23, 2026, reflecting increased investor demand [N2].
• On January 23, 2026, Helix Acquisition Corp. III announced the pricing of its upsized $150 million initial public offering [N3].

The company’s management team has relevant experience and industry connections that may facilitate identifying and completing a business combination in the healthcare sector. The successful completion of a $172.5 million IPO provides substantial capital to pursue acquisition targets. The strong liquidity position and clear governance structure support operational readiness for a business combination.

As a blank check company, Helix Acquisition Corp. III currently has no operations or revenue, and its success depends entirely on completing a suitable business combination. The target business may be financially unstable or in early development stages, which carries inherent risks. There is uncertainty regarding the timing and terms of any business combination, and the company may need to raise additional funds or incur debt, which could dilute existing shareholders or increase financial risk.

As a special purpose acquisition company (SPAC), Helix Acquisition Corp. III does not have a traditional competitive moat. Its value proposition lies in the management team's expertise and relationships in the healthcare sector, which may provide access to proprietary deal flow and investment opportunities. The company’s structure as a blank check company with capital held in trust provides investor protections but also limits operational activity until a business combination is completed.

• Dependence on Initial Business Combination: The company has no operations and relies entirely on completing a business combination to create value. Failure to complete a combination within the specified timeframe may result in liquidation and return of funds to shareholders.
• Target Business Risks: Potential acquisition targets may be financially unstable or in early stages, exposing the company to operational, financial, and market risks inherent in such businesses.
• Financing Risks: The company may need to raise additional capital through equity or debt to complete a business combination, which could dilute shareholders or increase financial obligations.
• Redemption Rights and Shareholder Approval: Public shareholders have redemption rights that may affect the availability of funds for the business combination. Shareholder approval may be required under certain conditions, potentially complicating or delaying transactions.

• Helix Acquisition Corp. III is a blank check company incorporated on September 10, 2025, formed to effect a business combination with one or more businesses, primarily targeting healthcare or healthcare-related industries [S1].
• The company has not engaged in any operations or generated revenue to date and is classified as a shell company with nominal assets consisting almost entirely of cash [S1].
• The company completed an initial public offering (IPO) on January 26, 2026, issuing 17,250,000 Class A ordinary shares at $10.00 per share, including a full exercise of the underwriters' over-allotment option, raising gross proceeds of $172.25 million [S1][N1].
• Simultaneously with the IPO, the company completed a private placement of 497,500 Class A ordinary shares to its sponsor at $10.00 per share, generating $4.975 million in gross proceeds [S1].
• The net proceeds from the IPO and private placement totaling $172.5 million were placed in a U.S.-based trust account, with funds restricted until the earlier of the initial business combination, redemption of public shares if no combination occurs within 24 months, or other specified redemption events [S1].
• The sponsor holds founder shares and has agreed to waive redemption rights on those shares and any public shares it holds in connection with the initial business combination [S1].
• The company’s management team is led by Chairperson and CEO Bihua Chen, supported by CFO Caleb Tripp and Chief Legal Officer Nebojsa Obradovic, with experience in identifying companies seeking financing as a path to public markets [S1].
• The company’s current assets as of June 30, 2026, were $2,362,356 and current liabilities were $192,001, resulting in a current ratio of 12.3, indicating strong liquidity [S2].
• Net income reported for the period ending June 30, 2026, was $1,334,048 [S2].
• The company intends to use the IPO proceeds and other financing sources to complete an initial business combination, potentially with a financially unstable or early-stage company, which carries inherent risks [S1].
• The company may raise additional funds through private offerings or debt in connection with the initial business combination and is not limited in issuing equity or debt securities for this purpose [S1].
• Public shareholders will have redemption rights in connection with the initial business combination, subject to certain conditions and limitations [S1].
• The company pays its sponsor monthly fees for office space, utilities, and administrative services, and may pay customary director fees [S1].
• There have been no material changes to risk factors disclosed in the Annual Report on Form 10-K as of the latest quarterly report [S2].
• Recent news confirms the closing of the $172.5 million IPO including full exercise of the underwriter's option, pricing of the upsized $150 million IPO, and related transactions in January 2026 [N1][N2][N3].